The mob wants Joe Rogan banned. Spotify removed 116 of his episodes.

But they refuse to totally ban Rogan, even as the White House demands that they do “more.”

When it comes to speech, where’s the line?

I say, let even the most controversial be heard

Over the course of the last week, a massive coordinated campaign to get Joe Rogan removed from Spotify began as a result of him hosting vaccine skeptical experts such as Dr. Robert Malone.  The campaign, which was supported by politicians as well as many prominent artists such as Neil Young, who removed his music from Spotify in a failed attempt to pressure them in to removing Rogan, took off on social media extremely quickly.  Yesterday, Spotify buckled to pressure from the activists and took 113 episodes of his podcast, the Joe Rogan Experience, off of their platform.  Reports claim that Rogan was pressured to remove the episodes after a viral video surfaced of him saying the N word on the podcast.  The highly edited video was created by a far left Super PAC.

Today, anti-censorship video platform Rumble made Joe Rogan an offer to exclusively host his content.  The platform offered him $100 Million, the same amount that Spotify offered Rogan to host his podcast.  They also promised to host his content free of censorship.

Rumble’s viewership over the last year has exploded as people seek a pro free speech alternative to YouTube and Spotify, who continue to impose harsher censorship measures in response to pressure from left wing activists, the media and politicians.  The platform claims that its active monthly users multiplied by 30 over the last year, from 1.6 million monthly active users in 2020 to 36 million in 2021.  Rumble is currently valued at roughly $2.1 Billion.

Over-the-counter aspirin could protect the lungs of Co v idd patients and minimize the need for mechanical ventilation, according to new research from George Washington University.

The team investigated more than 400 patients from hospitals across the United States who take aspirin unrelated to their CO V IDD disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.

“As we learned about the connection between blood clots and CO V IDD, we knew that aspirin – used to prevent stroke and heart attack – could be important for patients,” said Dr. Jonathan Chow of the study team. “Our research found an association between low-dose aspirin and decreased severity and death.”

Low-dose aspirin is a common treatment for anyone suffering from blood clotting issues or in danger of stroke, including most people who had a heart attack or a myocardial infarction. Although affecting the respiratory system, the coronavirus has been associated with small blood vessel clotting, causing tiny blockages in the pulmonary blood system, leading to ARDS – acute respiratory distress syndrome.

Israeli researchers reached similar results in a preliminary trial at the Barzilai Medical Center in March. In addition to its effect on blood clots, they found that aspirin carried immunological benefits and that the group taking it was 29% less likely to become infected with the virus in the first place.